Back to Medical Toxicology
Medical Toxicologyv2011Evidence-Based

Antivenom Dosing Algorithm

Doses antivenom (CroFab only, not Anavip) for pit viper snakebites. This unified treatment algorithm assists with quick identification and management of patients who may benefit from treatment with Crotalidae Polyvalent Immune Fab (CroFab®).

Clinical Input Parameters

kg
Range: 1 — 300 kg
Clinical Assessment
Awaiting Parameters
initial dose vials
—vials
Ready to Calculate

Awaiting Clinical Input

Enter the clinical input parameters on the left and click Run Clinical Assessment to evaluate this medical calculator with deterministic clinical scoring.

Open in Web App
Clinical decision support tool for licensed medical practitioners. Confirm independently before prescribing or clinical action.

When & Why to Use

The Antivenom Dosing Algorithm is utilized in clinical practice for risk stratification, diagnostic probability estimation, and treatment decision-making within medical toxicology.

Use this tool during initial patient intake, emergency department workup, or bedside assessment when objective clinical scoring is required to guide management or admission decisions.

Clinical Formula & Scoring Logic

Algorithm-based dosing: Initial dose 4-6 vials (up to 12 for severe cases), additional 4-6 vials if control not achieved, maintenance 2 vials q6h x 3 doses

Clinical Pearls & Practice Notes

  • Use only for symptomatic crotalid snake envenomation (pit vipers including rattlesnakes, cottonmouths, and copperheads) in the US
  • For CroFab administration only - do not use for Anavip dosing
  • Do not use for coral snake envenomation or non-US indigenous snakes
  • Not valid for snakebites on head/neck, snakebites causing rhabdomyolysis, or anaphylaxis/anaphylactoid reactions
  • Report all cases to poison control: 1-800-222-1222
  • Avoid: cutting/suctioning wound, ice, NSAIDs, prophylactic antibiotics, fasciotomy, electrical shock, steroids (unless allergic), tourniquets
  • Initial control requires: arrest of local effects, resolution of systemic effects, reduction of hematologic abnormalities
  • Maintenance therapy may not be needed if close physician-expert observation available
  • Follow-up: bleeding precautions for 2 weeks, lab monitoring at 2-3 days and 5-7 days post-discharge

Evidence & Literature Citations

  1. Lavonas EJ, Ruha AM, Banner W, et al. Unified treatment algorithm for the management of crotaline snakebite in the United States: results of an evidence-informed consensus workshop. BMC Emerg Med. 2011;11:2. doi: 10.1186/1471-227X-11-2
  2. Dart RC, Seifert SA, Boyer LV, et al. A randomized multicenter trial of crotalinae polyvalent immune Fab (ovine) antivenom for the treatment for crotaline snakebite in the United States. Arch Intern Med. 2001;161(16):2030-2036.
  3. CroFab® Prescribing Information. BTG International Inc.; August 2018.

Score Interpretation Ranges

No Treatment0 – 0 pts

No antivenom needed

Standard Initial Dose4 – 6 pts

Standard initial antivenom dose

Higher Initial Dose6 – 12 pts

Higher initial antivenom dose for severe cases

Need Clinical Suite Access?

Run this calculator with patient history, laboratory integration, and drug interaction safety checks on the DexaMed clinician app.

Open in Web App

Clinical Decision Support (CDS) Notice & Legal Disclaimer

This medical calculator and its scoring interpretation are provided strictly for licensed healthcare professionals and medical trainees as an educational and clinical decision support instrument. It does not replace independent clinical judgment, comprehensive patient history, physical examination, or attending physician oversight. Not FDA-cleared as an autonomous diagnostic medical device. Read the full DexaMed Medical Disclaimer.